secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2022-01-07T23:59:59+00:00
Accession:  0001104659-22-002314
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed director Stephen Hurst resigns from board effective immediately
-----------------------------------------------------------------------

- Stephen Hurst resigned as director of Mind Medicine (MindMed) on January 5, 2022.
- Resignation is not based on any disagreement with the Company or management.
- Hurst had served on the board since February 2020.
- CEO Robert Barrow thanked Hurst for his contributions and strategic guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465922002314/0001104659-22-002314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465922002314/tm222285d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-002314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer